Demographics and concomitant disorders in heart failure

被引:123
作者
Krum, H
Gilbert, RE
机构
[1] Monash Univ, Alfred Hosp, Sch Med,NHMRC Ctr Clin Res Excellence Therape, Dept Prevent Med, Melbourne, Vic 3181, Australia
[2] Monash Univ, Alfred Hosp, Sch Med,NHMRC Ctr Clin Res Excellence Therape, Dept Med, Melbourne, Vic 3181, Australia
[3] Monash Univ, Alfred Hosp, Sch Med,NHMRC Ctr Clin Res Excellence Therape, Dept Epidemiol, Melbourne, Vic 3181, Australia
[4] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia
关键词
D O I
10.1016/S0140-6736(03)13869-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic heart failure is an increasingly common cause of premature death and poor quality of life. Community-based epidemiological studies have provided much-needed information on the demography of chronic heart failure, providing insight into its influence on public health. In most patients, chronic heart failure Is accompanied by a range of concomitant disorders that both contribute to the cause of the disease and have a key role in its progression and response to treatment. Information on the most common comorbidities in chronic heart failure-ischaemic heart disease, hypertension, and diabetes mellitus-is presented for prespecifled subgroups in the reports of many large-scale, multicentre trials; despite their limitations, these subanalyses provide guidance in therapeutic decision-making. Similarly, because chronic heart failure is commonly an endpoint in intervention trials of both hypertension and diabetes, such studies afford important information on the prevention of chronic heart failure in these common diseases.
引用
收藏
页码:147 / 158
页数:12
相关论文
共 162 条
  • [1] Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
    Adler, AI
    Stratton, IM
    Neil, HAW
    Yudkin, JS
    Matthews, DR
    Cull, CA
    Wright, AD
    Turner, RC
    Holman, RR
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258): : 412 - 419
  • [2] Prevalence and aetiology of heart failure in an Arab population
    Agarwal, AK
    Venugopalan, P
    de Bono, D
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (03) : 301 - 305
  • [3] Andreas S, 2000, SLEEP, V23, pS220
  • [4] Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction
    Bauersachs, J
    Galuppo, P
    Fraccarollo, D
    Christ, M
    Ertl, G
    [J]. CIRCULATION, 2001, 104 (09) : 982 - 985
  • [5] DIABETIC CARDIOMYOPATHY - A UNIQUE ENTITY OR A COMPLICATION OF CORONARY-ARTERY DISEASE
    BELL, DSH
    [J]. DIABETES CARE, 1995, 18 (05) : 708 - 714
  • [6] LEFT-VENTRICULAR DIASTOLIC DYSFUNCTION AS A CAUSE OF CONGESTIVE-HEART-FAILURE - MECHANISMS AND MANAGEMENT
    BONOW, RO
    UDELSON, JE
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 117 (06) : 502 - 510
  • [7] REVERSIBLE ISCHEMIC LEFT-VENTRICULAR DYSFUNCTION - EVIDENCE FOR THE HIBERNATING MYOCARDIUM
    BRAUNWALD, E
    RUTHERFORD, JD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) : 1467 - 1470
  • [8] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    Brenner, BM
    Cooper, ME
    de Zeeuw, D
    Keane, WF
    Mitch, WE
    Parving, HH
    Remuzzi, G
    Snapinn, SM
    Zhang, ZX
    Shahinfar, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 861 - 869
  • [9] BRISTOW MR, 1996, CIRCULATION S, V94, P664
  • [10] BROPHY JM, 1992, CAN J CARDIOL, V8, P495